Catalyst Wire Dossier Catalyst Wire Dossier

PLK4 inhibitor (investigational)

Polo-like kinase 4 inhibitor · Repare Therapeutics
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PLK4 inhibitor (investigational), covering 2025-11-21 to 2025-11-21. Get the full timeline:

Most recent: Clinical Trial Update: LIONS (PLK4 Inhibitor in Advanced Solid Tumors) [Phase 1]

See pricing